The article mentions that there is a $100 variant floating around.
Makes me wonder whether they use the $100 variant in markets that $300 would be too much to pay.
If, is as reported, this virus is pulling in around ~$5million / annum, then that is a great basis for setting up a professional organisation to run the virus and extract maximum value from it.
